查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2112692

全球微型RNA市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global MicroRNA Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 209 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球微型RNA市場預計將從2025年的23.4億美元成長至2034年的76.6億美元，2026年至2034年的複合年成長率（CAGR）為14.08 % 。分子生物學和基因診斷領域的研究活性化，是推動全球微型RNA市場成長的主要動力。 microRNA在基因表現和疾病進展中發揮著至關重要的作用，是癌症和其他慢性疾病的重要生物標記。基因組學研究投入的增加也顯著促進了市場擴張。

關鍵成長要素包括RNA定序技術的進步和個人化醫療方法的日益普及。製藥公司正透過開發基於微型RNA的療法來加強其研發管線。政府資助和與學術機構的合作也促進了市場成長。

RNA遞送系統和診斷平台技術的進一步進步可望拓展其臨床應用。將微型RNA研究融入精準醫療策略，可望開闢新的治療途徑，並促進市場的長期發展。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面而實用的見解。每份報告都包含幾個關鍵組成部分，旨在讓您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場趨勢進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球微型RNA市場：依服務分類

  • 市場分析、洞察與預測
  • 檢體
  • 服務類型

第5章 全球微型RNA市場：依產品分類

  • 市場分析、洞察與預測
  • 裝置
  • 消耗品

第6章 全球微型RNA市場：依應用分類

  • 市場分析、洞察與預測
  • 癌症
  • 感染疾病
  • 免疫系統疾病
  • 心血管疾病
  • 神經系統疾病
  • 其他

第7章：全球微型RNA市場：依最終用途分類

  • 市場分析、洞察與預測
  • 生物技術和製藥公司
  • 學術和政府附屬研究機構
  • 其他

第8章 全球微型RNA市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Merck KGaA
    • Thermo Fisher Scientific Inc
    • Horizon Discovery Ltd
    • Synlogic
    • Qiagen
    • GeneCopoeia Inc
    • New England Biolabs
    • Quantabio
    • NanoString
    • BioGenex
    • SeqMatic LLC
    • Miltenyi Biotec
    • Sistemic Scotland Limited
    • Biodynamics Laboratory Inc
    • OriGene Tec
簡介目錄
Product Code: VMR112113295

The global microRNA market size is expected to reach USD 7.66 Billion in 2034 from USD 2.34 Billion in 2025, growing at a CAGR of 14.08% during 2026-2034.The global microRNA market is gaining momentum due to growing research in molecular biology and genetic diagnostics. MicroRNAs play a crucial role in gene regulation and disease progression, making them valuable biomarkers for cancer and other chronic conditions. Rising investments in genomics research are significantly supporting market expansion.

Key growth drivers include advancements in RNA sequencing technologies and increasing adoption of personalized medicine approaches. Pharmaceutical companies are exploring microRNA-based therapeutics, strengthening the research pipeline. Government funding and academic collaborations further contribute to market growth.

Looking ahead, technological improvements in RNA delivery systems and diagnostic platforms are expected to enhance clinical applications. The integration of microRNA research into precision medicine strategies may open new treatment opportunities, supporting long-term market development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Services

  • Specimen
  • Service Type

By Products

  • Instruments
  • Consumables

By Application

  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others

By End-Use

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Others

COMPANIES PROFILED

  • Merck KGaA, Thermo Fisher Scientific Inc., Horizon Discovery Ltd., Synlogic, Qiagen, GeneCopoeia Inc., New England Biolabs, Quantabio, NanoString, BioGenex, SeqMatic LLC, Miltenyi Biotec, Sistemic Scotland Limited, Biodynamics Laboratory Inc., OriGene Tec

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL MICRORNA MARKET: BY SERVICES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Services
  • 4.2. Specimen Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Service Type Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MICRORNA MARKET: BY PRODUCTS 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Products
  • 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MICRORNA MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Immunological Disorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Cardiovascular Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Neurological Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MICRORNA MARKET: BY END-USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-use
  • 7.2. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Academic & Government Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MICRORNA MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Services
    • 8.2.2 By Products
    • 8.2.3 By Application
    • 8.2.4 By End-use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Services
    • 8.3.2 By Products
    • 8.3.3 By Application
    • 8.3.4 By End-use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Services
    • 8.4.2 By Products
    • 8.4.3 By Application
    • 8.4.4 By End-use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Services
    • 8.5.2 By Products
    • 8.5.3 By Application
    • 8.5.4 By End-use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Services
    • 8.6.2 By Products
    • 8.6.3 By Application
    • 8.6.4 By End-use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MICRORNA INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Merck KGaA
    • 10.2.2 Thermo Fisher Scientific Inc
    • 10.2.3 Horizon Discovery Ltd
    • 10.2.4 Synlogic
    • 10.2.5 Qiagen
    • 10.2.6 GeneCopoeia Inc
    • 10.2.7 New England Biolabs
    • 10.2.8 Quantabio
    • 10.2.9 NanoString
    • 10.2.10 BioGenex
    • 10.2.11 SeqMatic LLC
    • 10.2.12 Miltenyi Biotec
    • 10.2.13 Sistemic Scotland Limited
    • 10.2.14 Biodynamics Laboratory Inc
    • 10.2.15 OriGene Tec